EPR - the future of bio/pharmaceutical analysis online summit 2025 logo

The Future of

Bio/Pharmaceutical Analysis

2025

Agenda Overview

Here is a summary of what to expect during the two-day virtual summit:

  • Artificial Intelligence in Bio/Pharmaceutical Industries

    Explore the transformative potential of AI and machine learning across pharmaceutical analysis, manufacturing, and quality control.

  • Global Guidelines for Analytical and Quality Standards

    Discuss updates and trends in international regulatory guidelines for analytical procedures and risk-based approaches to quality assessment.

  • Addressing Contaminants and Impurities in Pharmaceuticals

    Examine ongoing challenges and advancements in identifying and managing chemical impurities and contaminants in drug substances and products.

  • Advancing Cell and Gene Therapies 

    Explore the latest developments in manufacturing, testing, and regulatory frameworks for advanced therapeutic medicinal products.

  • Innovations in Quality Control Testing

    Highlight cutting-edge technologies and methods for ensuring pharmaceutical safety, purity, and efficacy, including endotoxin testing and other advancements.

  • Technological Integration in Continuous Manufacturing

    Discuss the role of process analytical technologies (PAT) in improving efficiency and consistency in continuous pharmaceutical manufacturing.

  • Next-Generation Biologics Characterisation

    Various analytical approaches for characterising complex biologics like antibody-drug conjugates and other therapeutic proteins.

  • Combatting Counterfeit Pharmaceuticals and Biologics

    Address global efforts, technologies, and strategies to detect and prevent counterfeit drugs and biologics.

  • Sustainability in Pharmaceutical Practices

    Examine how the pharmaceutical industry is adopting sustainable practices across manufacturing, testing, and quality control.

  • Regulatory and Technological Trends in Quality Assurance

    Provide insights into evolving regulatory expectations and the role of emerging technologies in maintaining pharmaceutical quality standards.

  • Environmental monitoring and contamination control in microbiological processes

    Strategies, technologies, and regulatory requirements that ensure a controlled environment for producing safe and effective pharmaceutical products.

  • Endotoxin Testing: Evolving Strategies for Enhanced Safety and Sustainability

    Exploring the latest advancements in endotoxin testing methodologies, regulatory updates, and sustainable practices.

  • Artificial Intelligence in Bio/Pharmaceutical Industries

    Explore the transformative potential of AI and machine learning across pharmaceutical analysis, manufacturing, and quality control.

  • Global Guidelines for Analytical and Quality Standards

    Discuss updates and trends in international regulatory guidelines for analytical procedures and risk-based approaches to quality assessment.

  • Addressing Contaminants and Impurities in Pharmaceuticals

    Examine ongoing challenges and advancements in identifying and managing chemical impurities and contaminants in drug substances and products.

  • Advancing Cell and Gene Therapies

    Explore the latest developments in manufacturing, testing, and regulatory frameworks for advanced therapeutic medicinal products.

  • Innovations in Quality Control Testing

    Highlight cutting-edge technologies and methods for ensuring pharmaceutical safety, purity, and efficacy, including endotoxin testing and other advancements.

  • Technological Integration in Continuous Manufacturing

    Discuss the role of process analytical technologies (PAT) in improving efficiency and consistency in continuous pharmaceutical manufacturing.

  • Next-Generation Biologics Characterisation

    Various analytical approaches for characterising complex biologics like antibody-drug conjugates and other therapeutic proteins.

  • Combatting Counterfeit Pharmaceuticals and Biologics

    Address global efforts, technologies, and strategies to detect and prevent counterfeit drugs and biologics.

  • Sustainability in Pharmaceutical Practices 

    Examine how the pharmaceutical industry is adopting sustainable practices across manufacturing, testing, and quality control.

  • Regulatory and Technological Trends in Quality Assurance

    Provide insights into evolving regulatory expectations and the role of emerging technologies in maintaining pharmaceutical quality standards.

  • Environmental monitoring and contamination control in microbiological processes

    Strategies, technologies, and regulatory requirements that ensure a controlled environment for producing safe and effective pharmaceutical products.

  • Endotoxin Testing: Evolving Strategies for Enhanced Safety and Sustainability

    Exploring the latest advancements in endotoxin testing methodologies, regulatory updates, and sustainable practices.